Antibiotic use in nasal bone fracture: a single-center retrospective study.
Antibiotic prophylaxis
Closed fracture reduction
Nasal bone
Journal
Archives of craniofacial surgery
ISSN: 2287-1152
Titre abrégé: Arch Craniofac Surg
Pays: Korea (South)
ID NLM: 101588280
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
received:
22
10
2021
accepted:
14
12
2021
entrez:
3
1
2022
pubmed:
4
1
2022
medline:
4
1
2022
Statut:
ppublish
Résumé
Prophylactic antibiotics are used to prevent surgical wound infection; however, proper indications must be followed with careful consideration of the risks and benefits, especially in clean or clean-contaminated wounds. Nasal bone fractures are the most common type of facial bone fracture. The most common method for treating nasal bone fracture is closed reduction, which is performed inside the nasal cavity without an incision. The purpose of this study was to determine the need for antibiotic use in the closed reduction of nasal bone fractures. A retrospective study was conducted using data from the National Insurance Service Ilsan Hospital of the Republic of Korea between 2016 and 2018. The records of patients who underwent closed reduction of nasal bone fracture were reviewed and classified according to sex, age, comorbidities, perioperative antibiotic usage, postoperative complications, nasal packing, anesthesia type, surgeon's specialty, and operation time. Among the 373 patients studied, the antibiotic prescription rate was 67.3%. Just 0.8% of patients were prescribed preoperative antibiotics only, 44.0% were prescribed postoperative antibiotics only, and 22.5% were prescribed both preoperative and postoperative antibiotics. There were no cases that satisfied the definition of "surgical site infection." Furthermore, 2.1% of infection-related complications (e.g., mucosal swelling, synechia, and anosmia) occurred only in the antibiotic usage group. The use of nasal packing, anesthesia type, and surgeon's specialty did not show any difference in infection-related complication rates. According to the study findings, the routine use of perioperative antibiotics is not recommended in uncomplicated nasal bone fracture surgery.
Sections du résumé
BACKGROUND
BACKGROUND
Prophylactic antibiotics are used to prevent surgical wound infection; however, proper indications must be followed with careful consideration of the risks and benefits, especially in clean or clean-contaminated wounds. Nasal bone fractures are the most common type of facial bone fracture. The most common method for treating nasal bone fracture is closed reduction, which is performed inside the nasal cavity without an incision. The purpose of this study was to determine the need for antibiotic use in the closed reduction of nasal bone fractures.
METHODS
METHODS
A retrospective study was conducted using data from the National Insurance Service Ilsan Hospital of the Republic of Korea between 2016 and 2018. The records of patients who underwent closed reduction of nasal bone fracture were reviewed and classified according to sex, age, comorbidities, perioperative antibiotic usage, postoperative complications, nasal packing, anesthesia type, surgeon's specialty, and operation time.
RESULTS
RESULTS
Among the 373 patients studied, the antibiotic prescription rate was 67.3%. Just 0.8% of patients were prescribed preoperative antibiotics only, 44.0% were prescribed postoperative antibiotics only, and 22.5% were prescribed both preoperative and postoperative antibiotics. There were no cases that satisfied the definition of "surgical site infection." Furthermore, 2.1% of infection-related complications (e.g., mucosal swelling, synechia, and anosmia) occurred only in the antibiotic usage group. The use of nasal packing, anesthesia type, and surgeon's specialty did not show any difference in infection-related complication rates.
CONCLUSION
CONCLUSIONS
According to the study findings, the routine use of perioperative antibiotics is not recommended in uncomplicated nasal bone fracture surgery.
Identifiants
pubmed: 34974687
pii: acfs.2021.00535
doi: 10.7181/acfs.2021.00535
pmc: PMC8721428
doi:
Types de publication
Journal Article
Langues
eng
Pagination
319-323Subventions
Organisme : National Health Insurance Service Ilsan Hospital
ID : NHIMC2021-CR-009
Références
Arch Craniofac Surg. 2020 Feb;21(1):7-14
pubmed: 32126614
Acta Otolaryngol Suppl. 2000;543:165-6
pubmed: 10909010
Arch Craniofac Surg. 2019 Apr;20(2):89-93
pubmed: 31048645
Am J Emerg Med. 2020 May;38(5):983-989
pubmed: 31839514
J Craniofac Surg. 2015 Nov;26(8):2299-303
pubmed: 26517453
Arch Craniofac Surg. 2020 Feb;21(1):3-6
pubmed: 32126613
Arch Surg. 1997 Mar;132(3):320-1
pubmed: 9125038
Arch Craniofac Surg. 2021 Oct;22(5):254-259
pubmed: 34732037
J Craniofac Surg. 2017 May;28(3):803-805
pubmed: 28468171
Surg Infect (Larchmt). 2013 Feb;14(1):73-156
pubmed: 23461695
Rhinology. 2008 Dec;46(4):267-70
pubmed: 19145993
Maxillofac Plast Reconstr Surg. 2014 Nov;36(6):266-72
pubmed: 27489845
Infect Control Hosp Epidemiol. 1992 Oct;13(10):606-8
pubmed: 1334988
J Trauma Acute Care Surg. 2018 Sep;85(3):444-450
pubmed: 29985240
Braz J Otorhinolaryngol. 2005 Nov-Dec;71(6):734-8
pubmed: 16878241
JAAPA. 2018 Apr;31(4):52-54
pubmed: 30973535
Br J Oral Maxillofac Surg. 2014 Apr;52(4):329-33
pubmed: 24602602
Am J Infect Control. 2008 Jun;36(5):309-32
pubmed: 18538699
Arch Craniofac Surg. 2018 Dec;19(4):270-274
pubmed: 30613088
Craniomaxillofac Trauma Reconstr. 2015 Mar;8(1):64-78
pubmed: 25709755